Enliven Therapeutics, Inc. (ELVN)
54.32
-1.91
(-3.40%)
USD |
NASDAQ |
Sep 11, 16:00
54.29
-0.03
(-0.06%)
After-Hours: 20:00
Enliven Therapeutics Total Liabilities (Quarterly) : 15.07M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.07M |
| March 31, 2026 | 11.49M |
| December 31, 2025 | 16.68M |
| September 30, 2025 | 14.75M |
| June 30, 2025 | 15.42M |
| March 31, 2025 | 14.27M |
| December 31, 2024 | 15.92M |
| September 30, 2024 | 17.03M |
| June 30, 2024 | 22.11M |
| March 31, 2024 | 25.06M |
| December 31, 2023 | 25.96M |
| September 30, 2023 | 12.29M |
| June 30, 2023 | 9.507M |
| March 31, 2023 | 11.45M |
| Date | Value |
|---|---|
| December 31, 2022 | 1.83M |
| September 30, 2022 | 1.818M |
| June 30, 2022 | 3.302M |
| March 31, 2022 | 9.19M |
| December 31, 2021 | 7.616M |
| September 30, 2021 | 7.654M |
| June 30, 2021 | 7.501M |
| March 31, 2021 | 6.093M |
| December 31, 2020 | 6.407M |
| September 30, 2020 | 5.477M |
| June 30, 2020 | 5.021M |
| March 31, 2020 | 5.128M |
| December 31, 2019 | 4.382M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 112.90M |
| Fulcrum Therapeutics, Inc. | 13.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 910.22M |
| Shareholders Equity (Quarterly) | 895.15M |
| Debt to Equity Ratio | 0.0017 |
| Current Ratio | 64.07 |
| Net Debt Paydown Yield | -0.01% |